TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
SLN

Silence Therapeutics PLC

Healthcare · Biotechnology

10.90$ +1.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Silence Therapeutics PLC (SLN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SLN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-9.5 -8.3 -10 -9.6 -17 1.7 -11 9.2 -57 -39 -54 -62
0.3 0.2 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.5 0.5 0.6
1.1 0.8 0.5 0.6 0.7 0.6 4.4 12 13 13 10 8.1
– – -1.4 -10 0.3 -0.3 7.5 6.9 2.8 – – –
0.0 -0.2 -1.0 0.7 -0.2 21 19 52 -19 -12 -26 10
0.3 0.9 0.5 0.2 0.2 0.0 0.5 1.8 0.5 0.0 0.2 0.1
-0.2 4.3 -4.7 13 -4.8 -15 9.6 12 -20 16 -18 -48
– – -0.1 0.0 0.0 – – – – – – –
– – – -0.4 -0.4 -0.4 -0.4 -0.2 -0.2 -0.2 – –
11 39 -0.1 0.0 0.3 5.3 15 41 53 25 114 0.0
1.0 35 -13 3.7 -21 -8.0 14 62 -33 -0.8 42 -110
-9.8 -9.1 -11 -9.8 -17 1.7 -11 7.4 -58 -39 -54 -62

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?